Advertisement
U.S. Markets open in 54 mins

Viking Therapeutics, Inc. (1VT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
60.78+1.58 (+2.67%)
As of 09:21AM CEST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

Currency in USD. All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
0
0
-
Operating Expense
124,677
100,827
70,355
55,682
42,662
-
Operating Income
-124,677
-100,827
-70,355
-55,682
-42,662
-
Net Non Operating Interest Income Expense
27,930
14,932
1,530
685
3,127
-
Other Income Expense
-
-
-42
7
40
4
Pretax Income
-96,745
-85,895
-68,867
-54,990
-39,495
-
Net Income Common Stockholders
-96,745
-85,895
-68,867
-54,990
-39,495
-
Diluted NI Available to Com Stockholders
-96,745
-85,895
-68,867
-54,990
-39,495
-
Basic EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Diluted EPS
-0.92
-0.91
-0.90
-0.71
-0.54
-
Basic Average Shares
88,507
94,347
76,834
77,198
72,597
-
Diluted Average Shares
88,507
94,347
76,834
77,198
72,597
-
Total Operating Income as Reported
-124,677
-100,827
-70,355
-55,682
-42,662
-
Total Expenses
124,677
100,827
70,355
55,682
42,662
-
Net Income from Continuing & Discontinued Operation
-96,745
-85,895
-68,867
-54,990
-39,495
-
Normalized Income
-96,747
-85,895
-68,825
-54,997
-39,535
-
Interest Income
28,004
15,020
1,589
703
3,233
-
Interest Expense
-
-
-
-
-
0
Net Interest Income
27,930
14,932
1,530
685
3,127
-
EBIT
-124,677
-100,827
-70,355
-55,682
-42,662
-
EBITDA
-124,381
-100,535
-70,064
-55,386
-42,385
-
Reconciled Depreciation
296
292
291
296
277
-
Net Income from Continuing Operation Net Minority Interest
-96,745
-85,895
-68,867
-54,990
-39,495
-
Total Unusual Items Excluding Goodwill
2
-
-42
7
40
4
Total Unusual Items
2
-
-42
7
40
4
Normalized EBITDA
-124,383
-100,535
-70,022
-55,393
-42,425
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-